Cargando…
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791245/ https://www.ncbi.nlm.nih.gov/pubmed/33437756 http://dx.doi.org/10.21037/atm-20-7228 |
| _version_ | 1783633570449850368 |
|---|---|
| author | Tsilimigras, Diamantis I. Pawlik, Timothy M. |
| author_facet | Tsilimigras, Diamantis I. Pawlik, Timothy M. |
| author_sort | Tsilimigras, Diamantis I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7791245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77912452021-01-11 Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma Tsilimigras, Diamantis I. Pawlik, Timothy M. Ann Transl Med Editorial AME Publishing Company 2020-12 /pmc/articles/PMC7791245/ /pubmed/33437756 http://dx.doi.org/10.21037/atm-20-7228 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Tsilimigras, Diamantis I. Pawlik, Timothy M. Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title | Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title_full | Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title_fullStr | Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title_full_unstemmed | Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title_short | Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| title_sort | sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791245/ https://www.ncbi.nlm.nih.gov/pubmed/33437756 http://dx.doi.org/10.21037/atm-20-7228 |
| work_keys_str_mv | AT tsilimigrasdiamantisi sorafenibplustransarterialchemoembolizationforunresectablehepatocellularcarcinoma AT pawliktimothym sorafenibplustransarterialchemoembolizationforunresectablehepatocellularcarcinoma |